Point Biopharma is based in Indianapolis, IN. It has raised $650M in total funding. Latest round: IPO.
Point Biopharma funding overview
Point Biopharma is based in Indianapolis, IN. Point Biopharma has raised $650M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in July 2021. The round record for Point Biopharma runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, Johnson & Johnson Innovation – JJDC, Inc., Surveyor Capital, Farallon Capital Management, BVF Partners, Boxer Capital and 5 others. 11 distinct backers are named across the disclosed rounds.
Point Biopharma at a glance
Total raised
$650M
Latest round
IPO
Latest round date
July 2021
Headquarters
Indianapolis, IN
Notable investors
RA Capital Management, Johnson & Johnson Innovation – JJDC, Inc., Surveyor Capital, Farallon Capital Management, BVF Partners, Boxer Capital, Sphera Healthcare, Woodline Partners LP
Frequently asked about Point Biopharma funding
How much has Point Biopharma raised?
Point Biopharma has raised $650M in total disclosed funding across the rounds on record.
Who has invested in Point Biopharma?
RA Capital Management, Johnson & Johnson Innovation – JJDC, Inc., Surveyor Capital, Farallon Capital Management, BVF Partners, Boxer Capital are named among the investors backing Point Biopharma.
What was the latest Point Biopharma funding round?
The most recent disclosed round is an IPO, announced in July 2021.
Where is Point Biopharma based?
Point Biopharma is based in Indianapolis, IN.
When did Point Biopharma last raise?
The last disclosed Point Biopharma round closed in July 2021 at IPO.
We update the Point Biopharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Indianapolis and their backers are listed below.
